{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:50:08Z","timestamp":1790027408711,"version":"4.0.1"},"publisher-location":"Cham","reference-count":72,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030203146","type":"print"},{"value":"9783030203153","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-20315-3_13","type":"book-chapter","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T05:05:44Z","timestamp":1563339944000},"page":"191-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bleeding Disorders Associated with Cancer"],"prefix":"10.1007","author":[{"given":"Simon","family":"Mantha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"issue":"3","key":"13_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D. Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, Wheatley K, Harrison CJ, Burnett AK, National Cancer Research Institute Adult Leukaemia Working Group (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354\u2013365. https:\/\/doi.org\/10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"issue":"7","key":"13_CR2","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","volume":"111","author":"J Serna de la","year":"2008","unstructured":"de la Serna J, Montesinos P, Vellenga E, Rayon C, Parody R, Leon A, Esteve J, Bergua JM, Milone G, Deben G, Rivas C, Gonzalez M, Tormo M, Diaz-Mediavilla J, Gonzalez JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood 111(7):3395\u20133402. https:\/\/doi.org\/10.1182\/blood-2007-07-100669","journal-title":"Blood"},{"issue":"4","key":"13_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2141.2000.01936.x","volume":"108","author":"E Bona Di","year":"2000","unstructured":"Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F, Mandelli F (2000) Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia. Br J Haematol 108(4):689\u2013695","journal-title":"Br J Haematol"},{"issue":"13","key":"13_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJM199904013401303","volume":"340","author":"JS Menell","year":"1999","unstructured":"Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA (1999) Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340(13):994\u20131004. https:\/\/doi.org\/10.1056\/NEJM199904013401303","journal-title":"N Engl J Med"},{"issue":"7","key":"13_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.leukres.2010.11.008","volume":"35","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Jiang M, Dai L, Zhang W, Wu D, Ruan C (2011) The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res 35(7):879\u2013884. https:\/\/doi.org\/10.1016\/j.leukres.2010.11.008","journal-title":"Leuk Res"},{"key":"13_CR6","unstructured":"Cesarman GM, Guevara CA, Hajjar KA (1994) An endothelial cell receptor for plasminogen\/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269(33):21198\u201321203"},{"issue":"9","key":"13_CR7","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V84.9.3001.3001","volume":"84","author":"T Koyama","year":"1994","unstructured":"Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N (1994) All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood 84(9):3001\u20133009","journal-title":"Blood"},{"issue":"1","key":"13_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","volume":"92","author":"A Falanga","year":"1998","unstructured":"Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Passerini CG, Gordon SG, Barbui T (1998) Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 92(1):143\u2013151","journal-title":"Blood"},{"issue":"2","key":"13_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MOH.0000000000000221","volume":"23","author":"S Mantha","year":"2016","unstructured":"Mantha S, Tallman MS, Soff GA (2016) What\u2019s new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia? Curr Opin Hematol 23(2):121\u2013126. https:\/\/doi.org\/10.1097\/MOH.0000000000000221","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"13_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12032-013-0478-y","volume":"30","author":"M Mitrovic","year":"2013","unstructured":"Mitrovic M, Suvajdzic N, Bogdanovic A, Kurtovic NK, Sretenovic A, Elezovic I, Tomin D (2013) International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation \u22656: a new predictor of hemorrhagic early death in acute promyelocytic leukemia. Med Oncol 30(1):478. https:\/\/doi.org\/10.1007\/s12032-013-0478-y","journal-title":"Med Oncol"},{"issue":"4","key":"13_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1600-0609.2011.01747.x","volume":"88","author":"H Chang","year":"2012","unstructured":"Chang H, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH, Lin TL, Hung YS, Tang TC (2012) Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Eur J Haematol 88(4):321\u2013328. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01747.x","journal-title":"Eur J Haematol"},{"issue":"9","key":"13_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","volume":"113","author":"MA Sanz","year":"2009","unstructured":"Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Buchner T, Dohner H, Burnett AK, Lo-Coco F (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 113(9):1875\u20131891. https:\/\/doi.org\/10.1182\/blood-2008-04-150250","journal-title":"Blood"},{"issue":"2","key":"13_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2141.2005.05750.x","volume":"131","author":"SA Olwill","year":"2005","unstructured":"Olwill SA, McGlynn H, Gilmore WS, Alexander HD (2005) All-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia. Br J Haematol 131(2):258\u2013264. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05750.x","journal-title":"Br J Haematol"},{"issue":"13","key":"13_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","volume":"129","author":"S Mantha","year":"2017","unstructured":"Mantha S, Goldman DA, Devlin SM, Lee JW, Zannino D, Collins M, Douer D, Iland HJ, Litzow MR, Stein EM, Appelbaum FR, Larson RA, Stone R, Powell BL, Geyer S, Laumann K, Rowe JM, Erba H, Coutre S, Othus M, Park JH, Wiernik PH, Tallman MS (2017) Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood 129(13):1763\u20131767. https:\/\/doi.org\/10.1182\/blood-2016-10-747170","journal-title":"Blood"},{"issue":"9","key":"13_CR15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00277-017-3042-6","volume":"96","author":"O Abla","year":"2017","unstructured":"Abla O, Ribeiro RC, Testi AM, Montesinos P, Creutzig U, Sung L, Di Giuseppe G, Stephens D, Feusner JH, Powell BL, Hasle H, Kaspers GJL, Dalla-Pozza L, Lassaletta A, Tallman MS, Locatelli F, Reinhardt D, Lo-Coco F, Hitzler J, Sanz MA (2017) Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Ann Hematol 96(9):1449\u20131456. https:\/\/doi.org\/10.1007\/s00277-017-3042-6","journal-title":"Ann Hematol"},{"issue":"8","key":"13_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341(8):586\u2013592. https:\/\/doi.org\/10.1056\/NEJM199908193410807","journal-title":"N Engl J Med"},{"issue":"4","key":"13_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1600-0609.2006.00711.x","volume":"77","author":"M Yanada","year":"2006","unstructured":"Yanada M, Matsushita T, Suzuki M, Kiyoi H, Yamamoto K, Kinoshita T, Kojima T, Saito H, Naoe T (2006) Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation. Eur J Haematol 77(4):282\u2013287. https:\/\/doi.org\/10.1111\/j.1600-0609.2006.00711.x","journal-title":"Eur J Haematol"},{"issue":"3","key":"13_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/1076029607302435","volume":"13","author":"A Dixit","year":"2007","unstructured":"Dixit A, Chatterjee T, Mishra P, Kannan M, Choudhry DR, Mahapatra M, Choudhry VP, Saxena R (2007) Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Clin Appl Thromb Hemost 13(3):292\u2013298. https:\/\/doi.org\/10.1177\/1076029607302435","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"13_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1055\/s-2001-18865","volume":"27","author":"T Barbui","year":"2001","unstructured":"Barbui T, Falanga A (2001) Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 27(6):593\u2013604. https:\/\/doi.org\/10.1055\/s-2001-18865","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"13_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/jth.12838","volume":"13","author":"J. Thachil","year":"2015","unstructured":"Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M, Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis (2015) Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost 13(4):671\u2013675. https:\/\/doi.org\/10.1111\/jth.12838","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"13_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"5","author":"H Saito","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, Hirayama A, Matsuda T, Asakura H, Nakashima M, Aoki N (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5(1):31\u201341. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02267.x","journal-title":"J Thromb Haemost"},{"issue":"5","key":"13_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s12185-017-2190-8","volume":"105","author":"Hisayuki Yokoyama","year":"2017","unstructured":"Yokoyama H, Takahashi N, Katsuoka Y, Inomata M, Ito T, Meguro K, Kameoka Y, Tsumanuma R, Murai K, Noji H, Ishizawa K, Ito S, Onishi Y, Harigae H, Tohoku Hematology Forum (2017) Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum. Int J Hematol 105(5):606\u2013613. https:\/\/doi.org\/10.1007\/s12185-017-2190-8","journal-title":"International Journal of Hematology"},{"issue":"6","key":"13_CR23","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1172\/JCI114107","volume":"83","author":"M Arai","year":"1989","unstructured":"Arai M, Scandella D, Hoyer LW (1989) Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J Clin Invest 83(6):1978\u20131984. https:\/\/doi.org\/10.1172\/jci114107","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"13_CR24","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"P. W. Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR, United Kingdom Haemophilia Centre Doctors\u2019 Organisation (2007) Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood 109(5):1870\u20131877. https:\/\/doi.org\/10.1182\/blood-2006-06-029850","journal-title":"Blood"},{"issue":"7","key":"13_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ajh.24777","volume":"92","author":"R Kruse-Jarres","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F, Collins PW, Knoebl P, Leissinger CA, Tiede A, Kessler CM (2017) Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 92(7):695\u2013705. https:\/\/doi.org\/10.1002\/ajh.24777","journal-title":"Am J Hematol"},{"issue":"1","key":"13_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","volume":"121","author":"J Delgado","year":"2003","unstructured":"Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A (2003) Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 121(1):21\u201335","journal-title":"Br J Haematol"},{"issue":"1","key":"13_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/hae.13355","volume":"24","author":"M Napolitano","year":"2018","unstructured":"Napolitano M, Siragusa S, Mancuso S, Kessler CM (2018) Acquired haemophilia in cancer: a systematic and critical literature review. Haemophilia 24(1):43\u201356. https:\/\/doi.org\/10.1111\/hae.13355","journal-title":"Haemophilia"},{"issue":"4","key":"13_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","volume":"6","author":"A Tiede","year":"2008","unstructured":"Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U (2008) Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 6(4):569\u2013576. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.02909.x","journal-title":"J Thromb Haemost"},{"issue":"08","key":"13_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/s-0037-1614018","volume":"84","author":"Jacob Rand","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE, Subcommittee on von Willebrand Factor (2000) Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84(2):345\u2013349","journal-title":"Thrombosis and Haemostasis"},{"issue":"12","key":"13_CR30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.20452\/pamw.3211","volume":"125","author":"A Mital","year":"2015","unstructured":"Mital A, Prejzner W, Bieniaszewska M, Hellmann A (2015) Prevalence of acquired von Willebrand syndrome during essential thrombocythemia: a retrospective analysis of 170 consecutive patients. Pol Arch Med Wewn 125(12):914\u2013920","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"13_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.17219\/acem\/52361","volume":"24","author":"A Mital","year":"2015","unstructured":"Mital A, Prejzner W, Hellmann A (2015) Acquired von Willebrand syndrome during the course of myelofibrosis: analysis of 32 cases. Adv Clin Exp Med 24(6):1001\u20131006. https:\/\/doi.org\/10.17219\/acem\/52361","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"13_CR32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.thromres.2015.07.029","volume":"136","author":"A Mital","year":"2015","unstructured":"Mital A, Prejzner W, Swiatkowska-Stodulska R, Hellmann A (2015) Factors predisposing to acquired von Willebrand syndrome during the course of polycythemia vera\u2014retrospective analysis of 142 consecutive cases. Thromb Res 136(4):754\u2013757. https:\/\/doi.org\/10.1016\/j.thromres.2015.07.029","journal-title":"Thromb Res"},{"issue":"7","key":"13_CR33","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/jth.12967","volume":"13","author":"S Lancellotti","year":"2015","unstructured":"Lancellotti S, Dragani A, Ranalli P, Petrucci G, Basso M, Tartaglione R, Rocca B, De Cristofaro R (2015) Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. J Thromb Haemost 13(7):1226\u20131237. https:\/\/doi.org\/10.1111\/jth.12967","journal-title":"J Thromb Haemost"},{"issue":"4","key":"13_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajh.10298","volume":"72","author":"S Kumar","year":"2003","unstructured":"Kumar S, Pruthi RK, Nichols WL (2003) Acquired von Willebrand\u2019s syndrome: a single institution experience. Am J Hematol 72(4):243\u2013247. https:\/\/doi.org\/10.1002\/ajh.10298","journal-title":"Am J Hematol"},{"issue":"6","key":"13_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MD.0b013e3182397166","volume":"90","author":"S Voisin","year":"2011","unstructured":"Voisin S, Hamidou M, Lefrancois A, Sigaud M, Mahe B, Trossaert M (2011) Acquired von Willebrand syndrome associated with monoclonal gammopathy: a single-center study of 36 patients. Medicine (Baltimore) 90(6):404\u2013411. https:\/\/doi.org\/10.1097\/MD.0b013e3182397166","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"13_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00277-016-2650-x","volume":"95","author":"C Dicke","year":"2016","unstructured":"Dicke C, Schneppenheim S, Holstein K, Spath B, Bokemeyer C, Dittmer R, Budde U, Langer F (2016) Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias. Ann Hematol 95(6):945\u2013957. https:\/\/doi.org\/10.1007\/s00277-016-2650-x","journal-title":"Ann Hematol"},{"issue":"3","key":"13_CR37","doi-asserted-by":"publisher","first-page":"e26246","DOI":"10.1002\/pbc.26246","volume":"64","author":"Emma Fosbury","year":"2016","unstructured":"Fosbury E, Szychot E, Slater O, Mathias M, Sibson K (2017) An 11-year experience of acquired von Willebrand syndrome in children diagnosed with Wilms tumour in a tertiary referral centre. Pediatr Blood Cancer 64(3). https:\/\/doi.org\/10.1002\/pbc.26246","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"13_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/hon.2292","volume":"34","author":"AM Ali","year":"2016","unstructured":"Ali AM, Mirrakhimov AE, Abboud CN, Cashen AF (2016) Leukostasis in adult acute hyperleukocytic leukemia: a clinician\u2019s digest. Hematol Oncol 34(2):69\u201378. https:\/\/doi.org\/10.1002\/hon.2292","journal-title":"Hematol Oncol"},{"issue":"10","key":"13_CR39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1164\/rccm.200206-554OC","volume":"167","author":"E Azoulay","year":"2003","unstructured":"Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall JR, Dombret H, Schlemmer B (2003) Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 167(10):1329\u20131333. https:\/\/doi.org\/10.1164\/rccm.200206-554OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"13_CR40","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C Rollig","year":"2015","unstructured":"Rollig C, Ehninger G (2015) How I treat hyperleukocytosis in acute myeloid leukemia. Blood 125(21):3246\u20133252. https:\/\/doi.org\/10.1182\/blood-2014-10-551507","journal-title":"Blood"},{"issue":"3","key":"13_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","volume":"115","author":"Ramon Garcia-Sanz","year":"2001","unstructured":"Garcia-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodriguez-Garcia JA, Masso P, Perez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Blade J, Miguel JF, Spanish Group for the Study of Waldenstrom Macroglobulinaemia and Pethema (2001) Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 115(3):575\u2013582","journal-title":"British Journal of Haematology"},{"issue":"1","key":"13_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1182\/asheducation-2007.1.158","volume":"2007","author":"C. S. Eby","year":"2007","unstructured":"Eby CS (2007) Bleeding and thrombosis risks in plasma cell dyscrasias. Hematol Am Soc Hematol Educ Program 158\u2013164. https:\/\/doi.org\/10.1182\/asheducation-2007.1.158","journal-title":"Hematology"},{"issue":"1","key":"13_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1172\/JCI112270","volume":"77","author":"G DiMinno","year":"1986","unstructured":"DiMinno G, Coraggio F, Cerbone AM, Capitanio AM, Manzo C, Spina M, Scarpato P, Dattoli GM, Mattioli PL, Mancini M (1986) A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. J Clin Invest 77(1):157\u2013164. https:\/\/doi.org\/10.1172\/JCI112270","journal-title":"J Clin Invest"},{"issue":"10","key":"13_CR44","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","volume":"119","author":"MJ Stone","year":"2012","unstructured":"Stone MJ, Bogen SA (2012) Evidence-based focused review of management of hyperviscosity syndrome. Blood 119(10):2205\u20132208. https:\/\/doi.org\/10.1182\/blood-2011-04-347690","journal-title":"Blood"},{"issue":"2","key":"13_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1365-2141.2000.02183.x","volume":"110","author":"AD Mumford","year":"2000","unstructured":"Mumford AD, O\u2019Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M (2000) Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 110(2):454\u2013460","journal-title":"Br J Haematol"},{"issue":"3","key":"13_CR46","first-page":"289","volume":"85","author":"G Gamba","year":"2000","unstructured":"Gamba G, Montani N, Anesi E, Palladini G, Capezzera M, Soldavini E, Merlini G (2000) Clotting alterations in primary systemic amyloidosis. Haematologica 85(3):289\u2013292","journal-title":"Haematologica"},{"issue":"11","key":"13_CR47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2169\/internalmedicine.32.879","volume":"32","author":"Y Hoshino","year":"1993","unstructured":"Hoshino Y, Hatake K, Muroi K, Tsunoda S, Suzuki T, Miwa A, Sakamoto S, Miura Y (1993) Bleeding tendency caused by the deposit of amyloid substance in the perivascular region. Intern Med 32(11):879\u2013881","journal-title":"Intern Med"},{"issue":"6","key":"13_CR48","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1182\/blood.V97.6.1885","volume":"97","author":"EB Choufani","year":"2001","unstructured":"Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC (2001) Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood 97(6):1885\u20131887","journal-title":"Blood"},{"issue":"2","key":"13_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJM197707142970203","volume":"297","author":"B Furie","year":"1977","unstructured":"Furie B, Greene E, Furie BC (1977) Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X. N Engl J Med 297(2):81\u201385. https:\/\/doi.org\/10.1056\/NEJM197707142970203","journal-title":"N Engl J Med"},{"issue":"14","key":"13_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM198104023041407","volume":"304","author":"B Furie","year":"1981","unstructured":"Furie B, Voo L, McAdam KP, Furie BC (1981) Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 304(14):827\u2013830. https:\/\/doi.org\/10.1056\/NEJM198104023041407","journal-title":"N Engl J Med"},{"issue":"12","key":"13_CR51","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ajh.23813","volume":"89","author":"A Litvak","year":"2014","unstructured":"Litvak A, Kumar A, Wong RJ, Smith L, Hassou H, Soff G (2014) Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis. Am J Hematol 89(12):1153\u20131154. https:\/\/doi.org\/10.1002\/ajh.23813","journal-title":"Am J Hematol"},{"issue":"3","key":"13_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajh.21603","volume":"85","author":"CA Thompson","year":"2010","unstructured":"Thompson CA, Kyle R, Gertz M, Heit J, Pruthi R, Pardanani A (2010) Systemic AL amyloidosis with acquired factor X deficiency: a study of perioperative bleeding risk and treatment outcomes in 60 patients. Am J Hematol 85(3):171\u2013173. https:\/\/doi.org\/10.1002\/ajh.21603","journal-title":"Am J Hematol"},{"issue":"19","key":"13_CR53","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJM197911083011907","volume":"301","author":"PR Greipp","year":"1979","unstructured":"Greipp PR, Kyle RA, Bowie EJ (1979) Factor X deficiency in primary amyloidosis: resolution after splenectomy. N Engl J Med 301(19):1050\u20131051. https:\/\/doi.org\/10.1056\/NEJM197911083011907","journal-title":"N Engl J Med"},{"issue":"1","key":"13_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","volume":"64","author":"AI Schafer","year":"1984","unstructured":"Schafer AI (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64(1):1\u201312","journal-title":"Blood"},{"issue":"2","key":"13_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0038-1657135","volume":"47","author":"FI Pareti","year":"1982","unstructured":"Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM (1982) Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemost 47(2):84\u201389","journal-title":"Thromb Haemost"},{"issue":"10","key":"13_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1056\/NEJM197809072991002","volume":"299","author":"Paul Kaywin","year":"1978","unstructured":"Kaywin P, McDonough M, Insel PA, Shattil SJ (1978) Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 299(10):505\u2013509. https:\/\/doi.org\/10.1056\/nejm197809072991002","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"13_CR57","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1309\/k58ewk4hpd51u3be","volume":"123","author":"JM Cesar","year":"2005","unstructured":"Cesar JM, de Miguel D, Avello AG, Burgaleta C (2005) Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Am J Clin Pathol 123(5):772\u2013777. https:\/\/doi.org\/10.1309\/k58ewk4hpd51u3be","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"13_CR58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128(3):275\u2013290. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05277.x","journal-title":"Br J Haematol"},{"issue":"2","key":"13_CR59","first-page":"95","volume":"71","author":"M Mittelman","year":"2000","unstructured":"Mittelman M, Zeidman A (2000) Platelet function in the myelodysplastic syndromes. Int J Hematol 71(2):95\u201398","journal-title":"Int J Hematol"},{"issue":"1\u20132","key":"13_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000314980","volume":"79","author":"S Hapani","year":"2010","unstructured":"Hapani S, Sher A, Chu D, Wu S (2010) Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis. Oncology (Williston Park) 79(1\u20132):27\u201338. https:\/\/doi.org\/10.1159\/000314980","journal-title":"Oncology (Williston Park)"},{"issue":"12","key":"13_CR61","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/annonc\/mdt292","volume":"24","author":"WX Qi","year":"2013","unstructured":"Qi WX, Tang LN, Sun YJ, He AN, Lin F, Shen Z, Yao Y (2013) Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials. Ann Oncol 24(12):2943\u20132952. https:\/\/doi.org\/10.1093\/annonc\/mdt292","journal-title":"Ann Oncol"},{"issue":"12","key":"13_CR62","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1093\/annonc\/mdx514","volume":"28","author":"D Arnold","year":"2017","unstructured":"Arnold D, Fuchs CS, Tabernero J, Ohtsu A, Zhu AX, Garon EB, Mackey JR, Paz-Ares L, Baron AD, Okusaka T, Yoshino T, Yoon HH, Das M, Ferry D, Zhang Y, Lin Y, Binder P, Sashegyi A, Chau I (2017) Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab. Ann Oncol 28(12):2932\u20132942. https:\/\/doi.org\/10.1093\/annonc\/mdx514","journal-title":"Ann Oncol"},{"issue":"28","key":"13_CR63","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.2012.42.8201","volume":"30","author":"E Cutsem Van","year":"2012","unstructured":"Van Cutsem E, Tabernero J, Lakomy R, Prenen H, Prausova J, Macarulla T, Ruff P, van Hazel GA, Moiseyenko V, Ferry D, McKendrick J, Polikoff J, Tellier A, Castan R, Allegra C (2012) Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol 30(28):3499\u20133506. https:\/\/doi.org\/10.1200\/JCO.2012.42.8201","journal-title":"J Clin Oncol"},{"issue":"5","key":"13_CR64","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/jth.13651","volume":"15","author":"JJ Shatzel","year":"2017","unstructured":"Shatzel JJ, Olson SR, Tao DL, McCarty OJT, Danilov AV, DeLoughery TG (2017) Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies. J Thromb Haemost 15(5):835\u2013847. https:\/\/doi.org\/10.1111\/jth.13651","journal-title":"J Thromb Haemost"},{"issue":"25","key":"13_CR65","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","volume":"373","author":"Jan A. Burger","year":"2015","unstructured":"Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Offner F, Mayer J, O\u2019Dwyer M, Hellmann A, Schuh A, Siddiqi T, Polliack A, Tam CS, Suri D, Cheng M, Clow F, Styles L, James DF, Kipps TJ, RESONATE-2 Investigators (2015) Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia. N Engl J Med 373(25):2425\u20132437. https:\/\/doi.org\/10.1056\/nejmoa1509388","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"13_CR66","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1182\/blood-2015-03-635326","volume":"126","author":"ML Wang","year":"2015","unstructured":"Wang ML, Blum KA, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, Williams ME, Barrientos JC, Chmielowska E, Radford J, Stilgenbauer S, Dreyling M, Jedrzejczak WW, Johnson P, Spurgeon SE, Zhang L, Baher L, Cheng M, Lee D, Beaupre DM, Rule S (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126(6):739\u2013745. https:\/\/doi.org\/10.1182\/blood-2015-03-635326","journal-title":"Blood"},{"issue":"9","key":"13_CR67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2298\/VSP150525076K","volume":"73","author":"A Kulic","year":"2016","unstructured":"Kulic A, Cvetkovic Z, Libek V (2016) Primary hyperfibrinolysis as the presenting sign of prostate cancer: a case report. Vojnosanit Pregl 73(9):877\u2013880. https:\/\/doi.org\/10.2298\/VSP150525076K","journal-title":"Vojnosanit Pregl"},{"issue":"6","key":"13_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0049-3848(92)90047-E","volume":"66","author":"K Okajima","year":"1992","unstructured":"Okajima K, Kohno I, Tsuruta J, Okabe H, Takatsuki K, Binder BR (1992) Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer. Thromb Res 66(6):717\u2013727","journal-title":"Thromb Res"},{"issue":"9","key":"13_CR69","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00108-007-1920-z","volume":"48","author":"C Aulmann","year":"2007","unstructured":"Aulmann C, Seufert P, Sandherr M, Schlimok G, Schulze R, Oruzio D (2007) A 65-year-old female patient with breast cancer accompanied by thrombocytopenia and hyperfibrinolysis. Internist (Berl) 48(9):1015\u20131019. https:\/\/doi.org\/10.1007\/s00108-007-1920-z","journal-title":"Internist (Berl)"},{"issue":"11","key":"13_CR70","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1200\/JCO.2009.25.2502","volume":"28","author":"HV Naina","year":"2010","unstructured":"Naina HV, Patnaik MM, Ali UA, Chen D, Ashrani AA (2010) Systemic fibrinolysis caused by tissue plasminogen activator-producing metastatic breast cancer. J Clin Oncol 28(11):e167\u2013e168. https:\/\/doi.org\/10.1200\/JCO.2009.25.2502","journal-title":"J Clin Oncol"},{"issue":"3","key":"13_CR71","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2003-40968","volume":"29","author":"M Kohli","year":"2003","unstructured":"Kohli M, Kaushal V, Mehta P (2003) Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 29(3):301\u2013308","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"13_CR72","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.7759\/cureus.428","volume":"7","author":"O Prokopchuk-Gauk","year":"2015","unstructured":"Prokopchuk-Gauk O, Brose K (2015) Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. Cureus 7(12):e428. https:\/\/doi.org\/10.7759\/cureus.428","journal-title":"Cureus"}],"container-title":["Cancer Treatment and Research","Thrombosis and Hemostasis in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-20315-3_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T01:22:23Z","timestamp":1721524943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-20315-3_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030203146","9783030203153"],"references-count":72,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-20315-3_13","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"18 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}